Publication | Open Access

A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens

Phase IiAdvanced Lung DiseaseMedicineRandomized StudyVersus PemetrexedCancer ManagementClinical TrialsPharmacotherapyCancer TreatmentOncologyRadiation OncologyLung CancerHealth Sciences